Opening ceremony of Uhlmann's new office in Singapore:

Uhlmann expands local expertise and focuses on service, engineering and local machine production

New Uhlmann Singapore LLP office expands competence locally with more than 60% floor space dedicated to machine production exported to neighbouring regions and globally?

Uhlmann Pac-Systeme, the family-owned company from Laupheim, Germany, is a global player that operates worldwide with a strong footprint across Southeast Asia. With the opening of its new office in Singapore, the world's leading supplier of pharmaceutical packaging systems is strengthening its presence in the area, demonstrating its commitment to the ASEAN region and showcasing its strong competence in production and services.

The new site combines over 2000 square meters of space for assembly and production (approx. 62%), offices (approx. 27%) as well as storage and warehousing purposes (approx. 11%). Uhlmann’s new office is almost 3 times bigger than the previous one and is thus strongly expanding its competence to support the critical pharma infrastructure in Singapore, exporting local machines to over 13 neighbouring regions and globally. Machines produced in Singapore include the B 1240 blister machine, C 130 cartoner machine and the B 200 blister machine.

B 1240 Blister Machine: This universal Blister machine for GMP-compliant packaging combines flexible packaging with an outstanding price-performance ratio. The Blister machine B 1240 is a servo-regulated, universal machine suitable for the packaging of both solid and parenteral products.

B 200 Blister Machine + C 130 Cartoner Machine: These two machines are part of an economical and flexible line for professional pharmaceutical packaging. The combination of Blister machine B 200 and the Cartoner C 130 offers an economical and flexible solution for efficient solid packaging into the direct link-up premium segment.

In recent years, there has been a noticeable rise in the number of biopharmaceutical companies establishing new manufacturing facilities in Singapore. This has transformed Singapore into a global centre with a skilled workforce specializing in the pharmaceutical sector. Uhlmann recognizes a potential opportunity to allocate resources towards showcasing our expertise, offering individually localized solutions, and be readily available. Uhlmann Singapore therefore focuses on capabilities for service, engineering and local machine production. The local Singapore team is able to consistently deliver top-notch service and support to its customers. This creates opportunities for job specific roles such as engineering, project management and sales.?

"Uhlmann’s expansion will add to the depth of capabilities and services that Singapore can offer to biopharma manufacturers locally and across the region. This growing ecosystem will help strengthen supply chain resilience for businesses here while enhancing the overall competitiveness of Singapore’s biomedical sciences sector. We are grateful for the partnership and confidence that Uhlmann has in Singapore and warmly welcome their expanded presence here” says Elaine Teo, Senior Vice President, Global Enterprises Division, Singapore Economic Development Board.?

For the official opening on 7 May 2024, invited honourees to attend the event include Elaine Teo and?the management team from Uhlmann Laupheim headquarters ( Tobias Uhlmann – Chairman of the Supervisor Board, Michael Mrachacz – CSO, Matthias Kaiser – VP Global Sales & Marketing), Henry Fang from Wonder Packing China, Mark van der Wolf CEO at Cremer Speciaalmachines B.V and over 13 regional partners representatives.

The new Uhlmann Singapore office is located at 11 Tampines Street 92, #01-02, Tampines Biz Hub, Singapore 528872.